WuXi AppTec Co., Ltd. Stock price

Equities

603259

CNE1000031K4

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. 07:00:00 2024-03-17 pm EDT 5-day change 1st Jan Change
53.41 CNY +4.09% Intraday chart for WuXi AppTec Co., Ltd. -2.48% -26.59%
Sales 2023 40.34B 5.6B Sales 2024 * 47.48B 6.6B Capitalization 151B 20.99B
Net income 2023 10.69B 1.49B Net income 2024 * 11.72B 1.63B EV / Sales 2023 5.12 x
Net cash position 2023 9.11B 1.27B Net cash position 2024 * 10.9B 1.51B EV / Sales 2024 * 2.95 x
P/E ratio 2023
22.5 x
P/E ratio 2024 *
13.5 x
Employees 41,148
Yield 2023
1.35%
Yield 2024 *
2.14%
Free-Float 66.79%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.09%
1 week-2.48%
Current month-1.96%
1 month+0.55%
3 months-27.35%
6 months-34.06%
Current year-26.59%
More quotes
1 week
48.80
Extreme 48.8
58.88
1 month
48.80
Extreme 48.8
60.52
Current year
45.20
Extreme 45.2
75.38
1 year
45.20
Extreme 45.2
93.56
3 years
45.20
Extreme 45.2
172.49
5 years
31.56
Extreme 31.5604
172.49
10 years
11.02
Extreme 11.0204
172.49
More quotes
Managers TitleAgeSince
Founder 54 00-11-30
Chief Executive Officer 56 00-11-30
Chief Executive Officer 55 15-11-30
Members of the board TitleAgeSince
Chief Investment Officer 61 06-12-31
Chief Executive Officer 56 00-11-30
Founder 54 00-11-30
More insiders
Date Price Change Volume
24-03-18 53.41 +4.09% 191,396,600
24-03-15 51.31 -4.11% 145,632,900
24-03-14 53.51 -5.71% 194,357,000
24-03-13 56.75 -0.79% 74,632,030
24-03-12 57.2 +4.44% 123,866,200

End-of-day quote Shanghai S.E., March 17, 2024

More quotes
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (60.9%): small molecules discovery services, bioanalytical services, medical devices safety testing services, comprehensive manufacturing and testing services for cell and gene therapies, etc.; - CMO and CDMO services (31.9%): development of manufacturing processes, production of advanced intermediates and active pharmaceutical ingredients, formulation development and dosage drug product manufacturing, for preclinical and clinical trials, new drug application, and commercial supply of chemical drugs, etc.; - clinical research services (7.1%): project planning, clinical operation and monitoring and managements of phase I-IV clinical trials, medical device trials, etc.; - other (0.1%). Net sales are distributed geographically as follows: China (25.1%), Asia (4.1%), the United States (53.6%), Europe (16%) and other (1.2%) .
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
53.41 CNY
Average target price
111.6 CNY
Spread / Average Target
+108.91%
Consensus
  1. Stock
  2. Equities
  3. Stock WuXi AppTec Co., Ltd. - Shanghai S.E.